MCMDC2
protein-codingminichromosome maintenance domain containing 2, the group of MCM family
Gene summary
Predicted to enable ATP binding activity and DNA binding activity. Predicted to be involved in double-strand break repair via break-induced replication. Predicted to act upstream of or within meiosis I cell cycle process; oogenesis; and spermatogenesis. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
- C8orf45
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~51.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MCMDC2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_173518.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | ||||
| missense | 66 | 2 | 2 | 70 | ||
| nonsense | 1 | 2 | 1 | 4 | ||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 1 | 2 | 68 | 2 | 3 | 76 |
Highest pathogenic variant AF is 0.00018465654
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_775789.3 | 14 | MANE Select | |
| Ensembl | ENSP00000413632.2 | 14 | MANE Select | |
| RefSeq | NP_001129632.1 | 13 | Standard | |
| RefSeq | NP_001129633.1 | 12 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- DNA replication initiation
- synaptonemal complex assembly
- spermatogenesis
- late meiotic recombination nodule assembly
- oogenesis
Molecular Function
- DNA binding
- ATP binding
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000422365
- Coding exons
- 14
- Length
- 51300
- Individuals with no LoFs
- 125555
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 187
- Defined
- 125742
- p
- 0.000744
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.07 | 269 | 323 | 0.833 | 0.0000151 | 4422 |
| Missense (PolyPhen) | 79 | 98.935 | 0.7985 | 1319 | ||
| Synonymous | 0.935 | 103 | 116 | 0.890 | 0.00000535 | 1309 |
| Loss of Function | 1.97 | 18 | 29.5 | 0.610 | 0.00000137 | 430 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00025 | rare |
| Latino/Admixed American | 0.00036 | 0.00029 | rare |
| Ashkenazi Jewish | 0.0017 | 0.0017 | notable |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.0029 | 0.0029 | notable |
| European (Non-Finnish) | 0.00078 | 0.00074 | rare |
| South Asian | 0.00014 | 0.00013 | rare |
| Other | 0.0010 | 0.00098 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plays an important role in meiotic recombination and associated DNA double-strand break repair. {ECO:0000250|UniProtKB:E9Q956}.;
Intolerance Scores
- RVIS EVS
- 1.16
- RVIS percentile EVS
- 92.59
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |